Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang CONBA Pharmaceutical Co Ltd's Subsidiary to Acquire Equity Shares


Tuesday, 19 Mar 2013 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd announced that its wholly owned subsidiary, a Hangzhou-based pharmaceutical company, will acquire a 29.04% stake and a 1.38% stake in a Yunnan-based pharmaceutical company, respectively from Zhang Hongshu and Cai Junkui, for RMB 111,565,100 and RMB 5,301,600. After that, the Company will directly and indirectly hold a 100% stake in the target company.